Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_assertion type Assertion NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_head.
- NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_assertion description "[Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_provenance.
- NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_assertion evidence source_evidence_literature NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_provenance.
- NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_assertion SIO_000772 11230485 NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_provenance.
- NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_assertion wasDerivedFrom befree-2016 NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_provenance.
- NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_assertion wasGeneratedBy ECO_0000203 NP309685.RA7RWSKobla56YvSWlhDB8xLf7puDIdxXzEteqK9vX7C4130_provenance.